LexAurum Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Buy
54,557
+90
+0.2% +$21K 1.6% 11
2026
Q1
$13.3M Buy
+54,467
New +$12.7M 1.73% 12
2025
Q3
$10.6M Buy
57,239
+1,600
+3% +$274K 1.51% 14
2025
Q2
$8.5M Sell
55,639
-221
-0.4% -$34K 1.34% 16
2025
Q1
$9.26M Buy
55,860
+205
+0.4% +$32.1K 1.78% 12
2024
Q4
$8.05M Buy
55,655
+913
+2% +$141K 1.59% 13
2024
Q3
$8.87M Buy
54,742
+128
+0.2% +$20.4K 1.95% 11
2024
Q2
$7.98M Sell
54,614
-241
-0.4% -$35.8K 1.95% 10
2024
Q1
$8.68M Sell
54,855
-402
-0.7% -$64K 2.18% 10
2023
Q4
$8.66M Sell
55,257
-106
-0.2% -$16.3K 2.27% 8
2023
Q3
$8.62M Sell
55,363
-57
-0.1% -$9.4K 2.52% 8
2023
Q2
$9.17M Buy
55,420
+374
+0.7% +$60.4K 2.76% 8
2023
Q1
$8.53M Buy
55,046
+39
+0.1% +$6.3K 2.83% 8
2022
Q4
$9.72M Sell
55,007
-672
-1% -$116K 3.48% 4
2022
Q3
$9.1M Buy
55,679
+260
+0.5% +$44K 3.52% 5
2022
Q2
$9.84M Sell
55,419
-30
-0.1% -$5.34K 3.68% 4
2022
Q1
$9.83M Sell
55,449
-2,681
-5% -$456K 3.21% 6
2021
Q4
$9.94M Sell
58,130
-596
-1% -$97.6K 3.24% 7
2021
Q3
$9.48M Buy
58,726
+59
+0.1% +$10.1K 2.8% 5
2021
Q2
$9.66M Buy
58,667
+890
+2% +$147K 2.86% 5
2021
Q1
$9.5M Buy
57,777
+1,159
+2% +$188K 3.25% 3
2020
Q4
$8.91M Buy
56,618
+212
+0.4% +$31.3K 3.19% 4
2020
Q3
$8.4M Buy
56,406
+1,001
+2% +$148K 3.45% 4
2020
Q2
$7.79M Buy
55,405
+2,757
+5% +$402K 4.26% 3
2020
Q1
$6.9M Buy
52,648
+4,231
+9% +$600K 4.79% 3
2019
Q4
$7.06M Sell
48,417
-238
-0.5% -$32.3K 3.49% 5
2019
Q3
$6.29M Buy
48,655
+210
+0.4% +$27.7K 3.73% 4
2019
Q2
$6.75M Buy
48,445
+258
+0.5% +$35.7K 4.17% 2
2019
Q1
$6.74M Buy
48,187
+316
+0.7% +$42.3K 4.46% 3
2018
Q4
$6.18M Buy
47,871
+621
+1% +$86.6K 4.78% 2
2018
Q3
$6.53M Buy
47,250
+188
+0.4% +$25K 4.58% 3
2018
Q2
$5.71M Buy
47,062
+524
+1% +$65.4K 5.07% 1
2018
Q1
$5.96M Buy
46,538
+42,822
+1,152% +$5.79M 5.05% 3
2017
Q4
$542K Buy
+3,716
New +$518K 0.51% 60

Other funds holding JNJ

LexAurum Advisors's JNJ Position: Q2 2026 in Review

LexAurum Advisors increased its Johnson & Johnson (JNJ) stake by 0.17% in Q2 2026, buying an estimated $21K and bringing the position to 54,557 shares worth $13.9M. The position accounts for 1.6% of the portfolio, ranked #11.

LexAurum Advisors first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • LexAurum Advisors held 54,557 shares of Johnson & Johnson worth $13.9M as of Q2 2026.
  • LexAurum Advisors bought 90 Johnson & Johnson shares in Q2 2026, an estimated $21K.
  • Johnson & Johnson made up 1.6% of LexAurum Advisors's portfolio in Q2 2026, its #11 holding.
  • LexAurum Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on LexAurum Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.